Another look at erythromycin
- PMID: 354037
Another look at erythromycin
Abstract
The erythromycins are broadly reviewed from a clinical viewpoint. The antimicrobial spectrum, clinical indications, pharmacokinetics and toxicity are dealt with. The usefulness of erythromycin for respiratory tract infections is stressed. New evidence to support bactericidal activity of this antibiotic is noted. There seems little reason to use the potentially hepatotoxic estolate form of erythromycin. The safety of the other forms of this antibiotic available in this country is emphasized.
Similar articles
-
A new look at erythromycin.Postgrad Med J. 1977 Apr;53(618):195-200. doi: 10.1136/pgmj.53.618.195. Postgrad Med J. 1977. PMID: 323837 Free PMC article. Review.
-
Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of erythromycin and its derivatives.Am J Hosp Pharm. 1979 Sep;36(9):1185-9. Am J Hosp Pharm. 1979. PMID: 386785 Review. No abstract available.
-
Erythromycin--three decades later.S Afr Med J. 1983 Aug 6;64(6):197-201. S Afr Med J. 1983. PMID: 6348968 Review.
-
Treatment of acute bacterial infections of the upper respiratory tract.Curr Med Res Opin. 1977;4(8):544-54. doi: 10.1185/03007997709115269. Curr Med Res Opin. 1977. PMID: 326492
-
[Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].Pathol Biol (Paris). 1988 May;36(5):544-7. Pathol Biol (Paris). 1988. PMID: 3043354 Clinical Trial. French.